Yau C - Search Results

1

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.

Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group. Lindström LS, et al. Among authors: yau c. J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270. J Natl Cancer Inst. 2018. PMID: 29361175 Free PMC article.

2

Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U, Benz CC. Zhou Y, et al. Among authors: yau c. Int J Biochem Cell Biol. 2005 May;37(5):1130-44. doi: 10.1016/j.biocel.2004.09.006. Int J Biochem Cell Biol. 2005. PMID: 15743683

3

Novel pathways associated with quinone-induced stress in breast cancer cells.

Benz CC, Atsriku C, Yau C, Britton D, Schilling B, Gibson BW, Baldwin MA, Scott GK. Benz CC, et al. Among authors: yau c. Drug Metab Rev. 2006;38(4):601-13. doi: 10.1080/03602530600959391. Drug Metab Rev. 2006. PMID: 17145690 Review.

4

Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer.

Marx C, Yau C, Banwait S, Zhou Y, Scott GK, Hann B, Park JW, Benz CC. Marx C, et al. Among authors: yau c. Mol Pharmacol. 2007 Jun;71(6):1525-34. doi: 10.1124/mol.107.034090. Epub 2007 Mar 28. Mol Pharmacol. 2007. PMID: 17392524

5

Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, Eppenberger U, Eppenberger-Castori S, Benz CC. Zhou Y, et al. Among authors: yau c. BMC Cancer. 2007 Apr 3;7:59. doi: 10.1186/1471-2407-7-59. BMC Cancer. 2007. PMID: 17407600 Free PMC article.

6

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC. Yau C, et al. Breast Cancer Res. 2007;9(5):R59. doi: 10.1186/bcr1765. Breast Cancer Res. 2007. PMID: 17850661 Free PMC article.

7

Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.

Yau C, Benz CC. Yau C, et al. Breast Cancer Res. 2008;10(4):R61. doi: 10.1186/bcr2120. Epub 2008 Jul 17. Breast Cancer Res. 2008. PMID: 18631401 Free PMC article.

8

Ageing, oxidative stress and cancer: paradigms in parallax.

Benz CC, Yau C. Benz CC, et al. Among authors: yau c. Nat Rev Cancer. 2008 Nov;8(11):875-9. doi: 10.1038/nrc2522. Nat Rev Cancer. 2008. PMID: 18948997 Free PMC article. Review.

9

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.

Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC. Yau C, et al. Breast Cancer Res. 2010;12(5):R85. doi: 10.1186/bcr2753. Epub 2010 Oct 14. Breast Cancer Res. 2010. PMID: 20946665 Free PMC article.

10

Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers.

Yau C, Wang Y, Zhang Y, Foekens JA, Benz CC. Yau C, et al. Breast Cancer Res Treat. 2011 Apr;126(3):803-10. doi: 10.1007/s10549-011-1345-1. Epub 2011 Jan 12. Breast Cancer Res Treat. 2011. PMID: 21225456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page